Justin Feng

Justin is currently Senior Associate at MRLV and serves as an Observer on the boards of Therini and ADRx. Prior to joining Merck, Justin was part of Johnson & Johnson where he was Senior Manager, External Innovation within the Transactions and Early Innovation Partnering team at the Boston Innovation Center. In this business development role, he supported both the pharmaceutical and consumer sectors in the sourcing and establishment of strategic partnerships. He led deals for the Immunology, Infectious Disease & Vaccine, Cardiovascular/Metabolism/Retinal, and Oncology therapeutic areas and was responsible for competitive landscaping, scientific diligence, business case development, negotiation, and contracting.

Prior to joining Johnson & Johnson Innovation, he was Principal Scientist at GRO Biosciences, where he led projects to develop enhanced protein therapeutics and enzymes using non-standard amino acids. Justin received his Ph.D. in biology as a National Science Foundation Graduate Fellow at Harvard Medical School in the lab of George Church. His thesis work focused on developing synthetic biology tools to engineer cells to sense and respond to chemical inputs. He received his undergraduate degree in Bioengineering at the University of California, Berkeley. Outside of work, Justin enjoys rock climbing and volunteering with organizations that focus on increasing diversity in STEM fields.